Europe Anti-Infective Agents Market
The Europe Anti-Infective Agents Market size was valued at US$ 41,446.62 Mn in 2022 and is projected to reach US$ 49,527.90 Mn by 2028, growing at a CAGR of 3.0% during 2022 - 2028.
Report Coverage
- Type: Anti-Viral, Anti-Bacterial, Anti-Fungal
- Range: Narrow Spectrum and Broad Spectrum
- Route of Administration: IV, Oral, Topical
- Indication: HIV, Tuberculosis, Respiratory Infection, Pneumonia
- Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Specialty Pharmacies, E-Commerce
US$ 41,446.62 Mn
Market size in 2022
US$ 49,527.90 Mn
Market Size by 2028
3.0%
CAGR, 2022 - 2028
2023-2028
Forecast Period
1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. Europe Anti-Infective Agents Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. Europe Anti-Infective Agents Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. Europe Anti-Infective Agents Market Regional Analysis
6.2 Europe Anti-Infective Agents Market Revenue 2020-2028 (US$ Million)
6.3 Europe Anti-Infective Agents Market Forecast Analysis
7. Europe Anti-Infective Agents Market Analysis – by Type
7.1 Anti-Viral
- 7.1.1 Overview
- 7.1.2 Anti-Viral: Europe Anti-Infective Agents Market – Revenue and Forecast, 2020-2028 (US$ Million)
7.2 Anti-Bacterial
- 7.2.1 Overview
- 7.2.2 Anti-Bacterial: Europe Anti-Infective Agents Market – Revenue and Forecast, 2020-2028 (US$ Million)
7.3 Anti-Fungal
- 7.3.1 Overview
- 7.3.2 Anti-Fungal: Europe Anti-Infective Agents Market – Revenue and Forecast, 2020-2028 (US$ Million)
8. Europe Anti-Infective Agents Market Analysis – by Range
8.1 Narrow Spectrum and Broad Spectrum
- 8.1.1 Overview
- 8.1.2 Narrow Spectrum and Broad Spectrum: Europe Anti-Infective Agents Market – Revenue and Forecast, 2020-2028 (US$ Million)
9. Europe Anti-Infective Agents Market Analysis – by Route of Administration
9.1 IV
- 9.1.1 Overview
- 9.1.2 IV: Europe Anti-Infective Agents Market – Revenue and Forecast, 2020-2028 (US$ Million)
9.2 Oral
- 9.2.1 Overview
- 9.2.2 Oral: Europe Anti-Infective Agents Market – Revenue and Forecast, 2020-2028 (US$ Million)
9.3 Topical
- 9.3.1 Overview
- 9.3.2 Topical: Europe Anti-Infective Agents Market – Revenue and Forecast, 2020-2028 (US$ Million)
10. Europe Anti-Infective Agents Market Analysis – by Indication
10.1 HIV
- 10.1.1 Overview
- 10.1.2 HIV: Europe Anti-Infective Agents Market – Revenue and Forecast, 2020-2028 (US$ Million)
10.2 Tuberculosis
- 10.2.1 Overview
- 10.2.2 Tuberculosis: Europe Anti-Infective Agents Market – Revenue and Forecast, 2020-2028 (US$ Million)
10.3 Respiratory Infection
- 10.3.1 Overview
- 10.3.2 Respiratory Infection: Europe Anti-Infective Agents Market – Revenue and Forecast, 2020-2028 (US$ Million)
10.4 Pneumonia
- 10.4.1 Overview
- 10.4.2 Pneumonia: Europe Anti-Infective Agents Market – Revenue and Forecast, 2020-2028 (US$ Million)
11. Europe Anti-Infective Agents Market – Europe Analysis
11.1 Overview
11.2 Europe- 11.2.1 Europe Anti-Infective Agents Market Breakdown, by Key Country, 2023 and 2028 (%)
- 11.2.1.1 Europe Anti-Infective Agents Market – Revenue and Forecast Analysis – by Country
- 11.2.1.1 UK: Europe Anti-Infective Agents Market – Revenue and Forecast to 2028 (US$ Million)
- 11.2.1.1.1 UK: Europe Anti-Infective Agents Market Breakdown, by Type
- 11.2.1.1.2 UK: Europe Anti-Infective Agents Market Breakdown, by Range
- 11.2.1.1.3 UK: Europe Anti-Infective Agents Market Breakdown, by Route of Administration
- 11.2.1.1.4 UK: Europe Anti-Infective Agents Market Breakdown, by Indication
- 11.2.1.2 Germany: Europe Anti-Infective Agents Market – Revenue and Forecast to 2028 (US$ Million)
- 11.2.1.2.1 Germany: Europe Anti-Infective Agents Market Breakdown, by Type
- 11.2.1.2.2 Germany: Europe Anti-Infective Agents Market Breakdown, by Range
- 11.2.1.2.3 Germany: Europe Anti-Infective Agents Market Breakdown, by Route of Administration
- 11.2.1.2.4 Germany: Europe Anti-Infective Agents Market Breakdown, by Indication
- 11.2.1.3 France: Europe Anti-Infective Agents Market – Revenue and Forecast to 2028 (US$ Million)
- 11.2.1.3.1 France: Europe Anti-Infective Agents Market Breakdown, by Type
- 11.2.1.3.2 France: Europe Anti-Infective Agents Market Breakdown, by Range
- 11.2.1.3.3 France: Europe Anti-Infective Agents Market Breakdown, by Route of Administration
- 11.2.1.3.4 France: Europe Anti-Infective Agents Market Breakdown, by Indication
- 11.2.1.4 Russia: Europe Anti-Infective Agents Market – Revenue and Forecast to 2028 (US$ Million)
- 11.2.1.4.1 Russia: Europe Anti-Infective Agents Market Breakdown, by Type
- 11.2.1.4.2 Russia: Europe Anti-Infective Agents Market Breakdown, by Range
- 11.2.1.4.3 Russia: Europe Anti-Infective Agents Market Breakdown, by Route of Administration
- 11.2.1.4.4 Russia: Europe Anti-Infective Agents Market Breakdown, by Indication
- 11.2.1.5 Italy: Europe Anti-Infective Agents Market – Revenue and Forecast to 2028 (US$ Million)
- 11.2.1.5.1 Italy: Europe Anti-Infective Agents Market Breakdown, by Type
- 11.2.1.5.2 Italy: Europe Anti-Infective Agents Market Breakdown, by Range
- 11.2.1.5.3 Italy: Europe Anti-Infective Agents Market Breakdown, by Route of Administration
- 11.2.1.5.4 Italy: Europe Anti-Infective Agents Market Breakdown, by Indication
- 11.2.1.6 Rest of Europe: Europe Anti-Infective Agents Market – Revenue and Forecast to 2028 (US$ Million)
- 11.2.1.6.1 Rest of Europe: Europe Anti-Infective Agents Market Breakdown, by Type
- 11.2.1.6.2 Rest of Europe: Europe Anti-Infective Agents Market Breakdown, by Range
- 11.2.1.6.3 Rest of Europe: Europe Anti-Infective Agents Market Breakdown, by Route of Administration
- 11.2.1.6.4 Rest of Europe: Europe Anti-Infective Agents Market Breakdown, by Indication
12. Competitive Landscape
12.1 Heat Map Analysis
12.2 Company Positioning and Concentration
13. Industry Landscape
13.1 Overview
13.2 Market Initiative
13.3 Partnerships and Collaborations
13.4 Other Developments
14. Company Profiles
14.1 Abbott
- 14.1.1 Key Facts
- 14.1.2 Business Description
- 14.1.3 Products and Services
- 14.1.4 Financial Overview
- 14.1.5 SWOT Analysis
- 14.1.6 Key Developments
14.2 Allergan Plc.
- 14.2.1 Key Facts
- 14.2.2 Business Description
- 14.2.3 Products and Services
- 14.2.4 Financial Overview
- 14.2.5 SWOT Analysis
- 14.2.6 Key Developments
14.3 Astellas Pharma Inc.
- 14.3.1 Key Facts
- 14.3.2 Business Description
- 14.3.3 Products and Services
- 14.3.4 Financial Overview
- 14.3.5 SWOT Analysis
- 14.3.6 Key Developments
14.4 Bayer AG
- 14.4.1 Key Facts
- 14.4.2 Business Description
- 14.4.3 Products and Services
- 14.4.4 Financial Overview
- 14.4.5 SWOT Analysis
- 14.4.6 Key Developments
14.5 Boehringer Ingelheim International GmbH
- 14.5.1 Key Facts
- 14.5.2 Business Description
- 14.5.3 Products and Services
- 14.5.4 Financial Overview
- 14.5.5 SWOT Analysis
- 14.5.6 Key Developments
14.6 Bristol-Myers Squibb Company
- 14.6.1 Key Facts
- 14.6.2 Business Description
- 14.6.3 Products and Services
- 14.6.4 Financial Overview
- 14.6.5 SWOT Analysis
- 14.6.6 Key Developments
14.7 F. Hoffmann-La Roche Ltd.
- 14.7.1 Key Facts
- 14.7.2 Business Description
- 14.7.3 Products and Services
- 14.7.4 Financial Overview
- 14.7.5 SWOT Analysis
- 14.7.6 Key Developments
14.8 Gilead Sciences, Inc.
- 14.8.1 Key Facts
- 14.8.2 Business Description
- 14.8.3 Products and Services
- 14.8.4 Financial Overview
- 14.8.5 SWOT Analysis
- 14.8.6 Key Developments
14.9 GlaxoSmithKline plc.
- 14.9.1 Key Facts
- 14.9.2 Business Description
- 14.9.3 Products and Services
- 14.9.4 Financial Overview
- 14.9.5 SWOT Analysis
- 14.9.6 Key Developments
14.10 Merck & Co., Inc.
- 14.10.1 Key Facts
- 14.10.2 Business Description
- 14.10.3 Products and Services
- 14.10.4 Financial Overview
- 14.10.5 SWOT Analysis
- 14.10.6 Key Developments
14.11 Novartis AG
- 14.11.1 Key Facts
- 14.11.2 Business Description
- 14.11.3 Products and Services
- 14.11.4 Financial Overview
- 14.11.5 SWOT Analysis
- 14.11.6 Key Developments
15. Appendix
15.1 About Business Market Insights
15.2 List of Abbreviations
Access the Full E Market Report
Get segment-level forecasts, regional estimates, competitive benchmarking, company profiles and downloadable Excel datasets.
